Annual Accounts Receivable
N/A
December 31, 2023
Summary
- ONCT annual accounts receivable is not available.
Performance
ONCT Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
N/A
September 30, 2024
Summary
- ONCT quarterly accounts receivable is not available.
Performance
ONCT Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ONCT Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
ONCT Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Oncternal Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2012 | - | $1.15 M(+26.9%) |
| Jun 2012 | - | $908.00 K(-1.8%) |
| Mar 2012 | - | $925.00 K(-5.7%) |
| Dec 2011 | $981.00 K(+43.6%) | $981.00 K(+18.2%) |
| Sep 2011 | - | $830.00 K(-8.2%) |
| Jun 2011 | - | $904.00 K(+32.9%) |
| Mar 2011 | - | $680.00 K(-0.4%) |
| Dec 2010 | $683.00 K(+68.2%) | $683.00 K(+34.2%) |
| Sep 2010 | - | $509.00 K(+37.9%) |
| Jun 2010 | - | $369.00 K(-28.9%) |
| Mar 2010 | - | $519.00 K(+27.8%) |
| Dec 2009 | $406.00 K | $406.00 K(+8.8%) |
| Sep 2009 | - | $373.00 K(-9.2%) |
| Jun 2009 | - | $411.00 K(-5.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2009 | - | $436.00 K(-10.5%) |
| Dec 2008 | $487.00 K(+316.2%) | $487.00 K(+245.4%) |
| Sep 2008 | - | $141.00 K(+16.5%) |
| Jun 2008 | - | $121.00 K(+23.5%) |
| Mar 2008 | - | $98.00 K(-16.2%) |
| Dec 2007 | $117.00 K(+91.8%) | $117.00 K(-5.6%) |
| Sep 2007 | - | $124.00 K(+15.9%) |
| Jun 2007 | - | $107.00 K(+57.4%) |
| Mar 2007 | - | $68.00 K(+11.5%) |
| Dec 2006 | $61.00 K(-60.1%) | $61.00 K(-99.8%) |
| Sep 2006 | - | $28.02 M(>+9900.0%) |
| Jun 2006 | - | $63.00 K(-7.4%) |
| Mar 2006 | - | $68.00 K(-55.6%) |
| Dec 2005 | $153.00 K | $153.00 K(-97.7%) |
| Mar 2004 | - | $6.78 M |
FAQ
- What is the all time high annual accounts receivable for Oncternal Therapeutics?
- What is the all time high quarterly accounts receivable for Oncternal Therapeutics?
What is the all time high annual accounts receivable for Oncternal Therapeutics?
Oncternal Therapeutics all-time high annual accounts receivable is $981.00 K
What is the all time high quarterly accounts receivable for Oncternal Therapeutics?
Oncternal Therapeutics all-time high quarterly accounts receivable is $28.02 M